| |
New CDC MMP Data on HIV in the U.S.
|
| |
| |
Download the PDF here
Summary
Today, the Centers for Disease Control and Prevention (CDC) published data from the 2024 cycle (June 2024–May 2025) of the Medical Monitoring Project (MMP). MMP is the only source of locally and nationally representative information on behavioral and clinical factors that affect HIV treatment success and risk of HIV transmission among U.S. adults with HIV. This data release can be used to monitor progress towards national and local HIV prevention and treatment goals and inform planning and resource allocation to improve the health and well-being of people with HIV.
Key findings from the 2024 MMP cycle include:
Antiretroviral therapy (ART) use is high, but adherence remains a challenge-especially among younger people with HIV.
Structural and other factors continue to negatively impact people with HIV in the United States
Eliminating barriers to accessing and using HIV prevention strategies could reduce HIV transmission risk
Many people with HIV have unmet needs for services that support their health. Access to ancillary services could help people with HIV maintain their well-being, but many have unmet needs for services, including dental care (24%), meal or food services (15%), and shelter or housing services (15%).
|
|
| |
| |
|
|
|
